Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
Abiraterone
Cat No.
CEI-1197
Description
Abiraterone is a potent inhibitor of CYP17 with IC50 of 2 nM.
Product Overview
Abiraterone (17-(3-pyridyl)androsta-5,16-dien-3β-ol) is a potent small-molecule inhibitor of CYP17 complex (17 alpha-monooxygenase) which is a member of the cytochrome P450 family consisting of 17 alpha-hydroxylase and C17,20-lyase and catalyzing the 17 alpha-hydroxylation of intermediates of steroid biosynthesis involved in testerone sysnthesis. Abiraterone inhibits CYP17 complex by binding to the haem iron of CYP17A1, which forms a 60o angle above the haem plane and packs against the central I helix with 3β-OH interacting with aspargine 202 in the F helix. Abiraterone is currently being investigated to treat late stage prostate cancer, in which it consistently suppresses testosterone levels, leads to significant reduction in PSA level, and prolong life in patients with castration-resistant prostate cancer (CRPC).
CAS No.
154229-19-3
Molecular Weight
349.52
Purity
0.9819
Storage
Store at -20°C
Synonyms
CB 7598,16-dien-3-ol,CB7598
Targets
CYP17
IC50
2 nM
Molecular Formula
C24H31NO
Chemical Name
(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol
Solubility
Limited solubility
Shipping Conditions
Evaluation sample solution: ship with blue ice. All other available size: ship with RT, or blue ice upon request
Download
Download Datasheet